Showing results (181-190 of 433) with videos related to

Sort By:
Pageof 44
American Heart Journal|November 2, 2013
Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction studyAkshay Bagai, Paul W Armstrong, Amanda Stebbins, et al.
American Heart Journal|July 31, 2013
Long-term outcomes among older patients with non-ST-segment elevation myocardial infarction complicated by cardiogenic shockAkshay Bagai, Anita Y Chen, Tracy Y Wang, et al.
Plos One|March 12, 2021
Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population levelAnthony Ming-Yu Chuang, Mau T Nguyen, Ehsan Khan, et al.
American Heart Journal|January 6, 2005
Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trialHoward A Cooper, Michael J Domanski, Yves Rosenberg, et al.
American Heart Journal|March 30, 2006
Concerning the mechanism of pexelizumab's benefit in acute myocardial infarctionPaul W Armstrong, Kenneth W Mahaffey, Wei-Ching Chang, et al.
Cardiovascular Drugs and Therapy|July 19, 2005
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction riskAdriaan A Voors, Pieter J de Kam, Maarten P van den Berg, et al.
Archives of Internal Medicine|October 24, 2007
Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO VHarmony R Reynolds, Michael E Farkouh, A Michael Lincoff, et al.
Acute Cardiac Care|March 25, 2014
The association between experience and proficiency with robotic-enhanced coronary intervention-insights from the PRECISE multi-center studyGiora Weisz, Nathaniel R Smilowitz, D Christopher Metzger, et al.
Circulation. Cardiovascular Quality and Outcomes|February 26, 2025
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA TrialJames Slater, David J Maron, Philip G Jones, et al.
American Heart Journal|December 24, 2003
Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromesMonvadi B Srichai, Wael A Jaber, David L Prior, et al.
Pageof 44